GILD Gilead Sciences Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
21:52
Oct 12
Oct 12
Bloomberg Markets
Acquisitions drive Gilead growth
Names Gilead as one of her health care names and thinks its acquisitions give the company further growth.
GILD
Gilead Sciences Inc.
Long
1ST
—
—
22:20
Sep 09
Sep 09
r/biotech
Kite/Gilead better cell therapy position than BMS
The author considers Kite/Gilead a better cell therapy position than BMS, implying relative advantage as the field moves past BCMA targets. The mechanism is Kite's non-BCMA cell therapy pipeline positioning Gilead favorably versus BMS. No catalyst or time horizon is given. Main risk is the author offers no pipeline or financial evidence to support the claim.
GILD
Gilead Sciences Inc.
Long
1ST
—
—
About GILD Investor Commentary
Across the available history and selected sources, Buzzberg tracks GILD (Gilead Sciences Inc.) across 14 sources: 10 bullish vs 0 bearish calls from 25 authors. Historical directional balance: 23% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 44 total trade ideas tracked. Past 7 days, before deduplication: 13 other directions. Latest voices: A May MD, Stephanie Guild, u/Loose-Reflection2965.